TOFASYKE-5 TABLETS
TOFASYKE-5 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | TOFASYKE-5 Tablets |
| Form | Oral Tablets |
| Key Ingredient | Tofacitinib 5 mg |
| Therapeutic Class | Janus Kinase (JAK) Inhibitor |
| Core Benefits | Reduces inflammation, joint damage, and autoimmune symptoms |
| Mechanism of Action | Inhibits JAK enzymes to regulate immune signaling and inflammation |
| Support Areas | Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis |
Brand Name : Tofasyke-5 Tablets Description : TOFASYKE-5 Tablets contain Tofacitinib 5 mg, an advanced Janus kinase (JAK) inhibitor used in the treatment of autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib works by modulating the immune response and reducing inflammation in affected joints or tissues. It helps relieve symptoms like joint pain, stiffness, and swelling, improving physical function and quality of life. TOFASYKE-5 is generally prescribed when conventional disease-modifying antirheumatic drugs (DMARDs) are not effective.